...royalties on SOLX-based products with maximum royalties of $14 million. Haemonetics Corp. (NYSE:HAE), Braintree, Mass. Hemerus Medical LLC...

...to close in Haemonetics' second fiscal quarter ending Sept. 30. Haemonetics Corp. (NYSE:HAE), Braintree, Mass. Hemerus Medical LLC...

...a joint venture with Hemerus to research filter technology applications for use in laboratory environments. Hemerus Medical LLC...

...increased 15% to $38.3 million. TECH also disclosed that it purchased a 10% interest in Hemerus Medical...